# The Procter & Gamble Manufacturing Company, Phoenix, AZ – FDA Inspections

Source: https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/c23efaf8-7ca9-487e-8673-c7ba4ae59e53

> Inspection records and compliance data for The Procter & Gamble Manufacturing Company in Phoenix, Arizona. 7 FDA inspections on record, last inspected June 03, 2022.

---

## Details

- Name: The Procter & Gamble Manufacturing Company
- FEI Number: 2021299
- Address Line 1: 2050 S 35th Ave
- City: Phoenix
- State: Arizona
- Zip Code: 85009
- Country Name: United States
- Address: 2050 S 35th Ave, Phoenix, Arizona 85009, United States
- Country: United States

## Related Documents

- FDA Inspection 1173057 - The Procter & Gamble Manufacturing Company - 2022-06-03 — classification: No Action Indicated (NAI), source: FDA, date: June 3, 2022
- FDA Inspection 1120284 - The Procter & Gamble Manufacturing Company - 2020-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2020
- FDA Inspection 1120284 - The Procter & Gamble Manufacturing Company - 2020-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2020
- [EIR - The Procter & Gamble Manufacturing Company - 2016-08-15](https://www.keypedia.com/records/eir/the-procter-gamble-manufacturing-company/1064e106-831e-4b1f-98a1-1255d1f83caf) — source: FDA, date: August 15, 2016
- FDA Inspection 987633 - The Procter & Gamble Manufacturing Company - 2016-08-15 — classification: No Action Indicated (NAI), source: FDA, date: August 15, 2016
- [FDA Inspection 781358 - The Procter & Gamble Manufacturing Company - 2012-05-11](https://www.keypedia.com/records/fda_inspections/the-procter-gamble-manufacturing-company/ab685273-6a84-44be-990f-7f61368c0788) — classification: No Action Indicated (NAI), source: FDA, date: May 11, 2012
- [FDA Inspection 720198 - The Procter & Gamble Manufacturing Company - 2011-04-15](https://www.keypedia.com/records/fda_inspections/the-procter-gamble-manufacturing-company/aa573614-4f3c-4cd7-81e6-50a9785ea6ed) — classification: No Action Indicated (NAI), source: FDA, date: April 15, 2011
- FDA Inspection 633906 - The Procter & Gamble Manufacturing Company - 2009-12-09 — classification: No Action Indicated (NAI), source: FDA, date: December 9, 2009
- FDA Inspection 613060 - The Procter & Gamble Manufacturing Company - 2009-09-17 — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2009

## Related Companies

- [Particle Dynamics International LLC](https://www.keypedia.com/companies/particle-dynamics-international-llc/db953a3d-b17e-41fa-8606-a4fee44373c1)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)

## Related Officers

- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)
- [company_representative](https://www.keypedia.com/people/janeen-lyle/4e3111e6-58d3-423a-badc-96abb269e12c)
